Key result
CCTA-determined three-vessel or left main disease is linked to ~341% greater risk of major events.
Why the study?
The 3.5-year prognosis of stable coronary artery disease evaluated by coronary computed tomography angiography in real-world clinical practice, overall and across demographic and comorbidity subgroups, needed examination.
Does the severity of coronary artery disease determined by CCTA predict the risk of late revascularization, myocardial infarction, and all-cause death in patients with new-onset symptoms suggestive of CAD?
Population
16,949 patients with new-onset symptoms suggestive of CAD undergoing CCTA
Comparison
Patients with CAD (by severity) vs patients without CAD
Design
Multicentre cohort study
Follow-up
3.5 years
Authors
Loading...
CCTA stratifies 3.5-year risk in symptomatic stable CAD; extends prior cohorts but leaves open effects on management and outcomes.
Cohort (n=16,949)
Yes
Does the severity of coronary artery disease determined by CCTA predict the risk of late revascularization, myocardial infarction, and all-cause death in patients with new-onset symptoms suggestive of CAD?
Effect estimate: HR 4.41 (95% CI 2.90-6.69)
Absolute Event Rate: 15% vs 1.5%
CCTA-determined CAD severity strongly predicts the 3.5-year risk of late revascularization, myocardial infarction, and death in patients with stable symptoms.
Nielsen et al. (2016) conducted a cohort in stable coronary artery disease (n=16,949). Coronary computed tomography angiography (CCTA) vs. Patients without CAD was evaluated on composite of late coronary revascularization procedure >90 days after CCTA, myocardial infarction, and all-cause death (HR 4.41, 95% CI 2.90-6.69). CCTA-determined CAD severity predicted the 3.5-year risk of late revascularization, MI, and death, with hazard ratios up to 4.41 (95% CI 2.90-6.69) for three-vessel/left main disease.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: